Welcome to our dedicated page for American Well SEC filings (Ticker: AMWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Well Corporation filings document the company’s SaaS-based technology-enabled healthcare platform, operating results, customer agreements, governance, and equity-compensation structure. Its Form 8-K filings include earnings reports for quarterly and annual periods, material definitive agreements, board changes, and related exhibit disclosures.
AMWL filings also describe commercial arrangements tied to digital care delivery, including the company’s operation of a white-labeled platform under the LiveHealth Online brand for Elevance Health and related clinical-provider access through Online Care Group. Proxy materials cover director elections, executive compensation, equity awards, stockholder voting matters, and board governance for the public company.
Ido Schoenberg, Chairman and co-CEO of American Well Corp (AMWL), received a grant of 50,000 restricted stock units (RSUs) on 08/13/2025. The RSUs vest in equal installments over three years, with vesting on each of the first, second and third anniversaries of the grant date. After the reported transaction, the filing shows 114,250 shares of Class A common stock beneficially owned directly and an additional 136,891 shares of Class A common stock beneficially owned indirectly through his wife.
Selected financials (June 30, 2025)
Q2 revenue $70,898; three‑month net loss $19,531 (net loss attributable to American Well $19,696; EPS $(1.24)). Six months revenue $137,731; net loss $37,887 (attributable $38,400).
Balance sheet: cash and cash equivalents $219,072; total assets $388,656; total liabilities $94,083; total stockholders' equity $294,573; accumulated deficit $(2,004,326). Deferred revenue $43,259; transaction price allocated to remaining performance obligations $84,725 (71% expected in the 12 months ending June 30, 2026).
- Revenue mix: platform subscription $40,460; visits $22,752; other $7,686 (Q2).
- Divestiture: sale of APC business closed Jan 8, 2025; net proceeds reported $20,400 and a gain of $10,713 recognized in H1 2025.
Selected financials (June 30, 2025)
Q2 revenue $70,898; three‑month net loss $19,531 (net loss attributable to American Well $19,696; EPS $(1.24)). Six months revenue $137,731; net loss $37,887 (attributable $38,400).
Balance sheet: cash and cash equivalents $219,072; total assets $388,656; total liabilities $94,083; total stockholders' equity $294,573; accumulated deficit $(2,004,326). Deferred revenue $43,259; transaction price allocated to remaining performance obligations $84,725 (71% expected in the 12 months ending June 30, 2026).
- Revenue mix: platform subscription $40,460; visits $22,752; other $7,686 (Q2).
- Divestiture: sale of APC business closed Jan 8, 2025; net proceeds reported $20,400 and a gain of $10,713 recognized in H1 2025.